Croatia
BMI has introduced greater clarity to its core views for the Pharmaceuticals & Healthcare. Short-term core views concern the period through to the end of the 2011-2013 patent cliff,...
2010-03-15Industry
BMI forecasts that pharmaceutical sales in Emerging Europe will grow by 125% over the next decade, representing a compound annual growth rate (CAGR) of 8.43%. With global sales projected...
2010-01-05Industry
BMI's regional outlook for pharmaceutical companies in Emerging Europe has improved marginally, following an update to our Pharmaceuticals & Healthcare Business Environment Ratings....
2009-10-30Industry
Global specialty pharmaceutical company Hospira has acquired the global rights to Teva Pharmaceutical Industries' biosimilar filgrastim, expanding its presence in the potentially...
2009-10-02Industry
Croatia's Ministry of Health has pledged to slash waiting lists in the country through a combination of merging of regional waiting lists and procuring additional services from the...
2008-10-22Industry
The inability of Croatia's Institute for Health Insurance (HZZO) to keep up with the growing demand for pharmaceuticals is having a damaging effect on pharmacies throughout the country....
2008-07-18Industry
Croatian drugmaker Pliva has divested its Spanish operations as it brings to a close its strategy of de-coupling its non-core assets in Europe. Pliva hopes the streamlining will...
2008-01-24Industry
Croatia increased its expenditure on reimbursed drugs by 4.2% in 2006, an outcome that BMI views as surprising considering that we expected most of the mandated 7% budget increase...
2007-12-05


